Has Stephen Murphy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,981,591 in general payments to Stephen Murphy, MD across 120 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stephen Murphy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stephen Murphy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stephen Murphy, MD

Orthopaedic Surgery · Roxbury Crossing, MANPI 1144267899

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $7,924,623 of the $7,981,591 with a category attached, or 99.3%. Microport Orthopedics Inc accounts for 69.4% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $3,212,460 and has fallen 73.5% since, to $849,791 in 2025. Among orthopaedic surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,981,591in general payments, 2019–2025

Across 120 payments — averaging $66,513 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Microport Orthopedics Inc$5.5M
Surgical Planning Associates, Inc.$2.4M
Zimmer Biomet$8K
Stryker$593
Smith+Nephew$406
Wishbone Medical Inc.$150
plus $184 from 4 others

$10,000in ownership & investment interests, 2019–2025

Across 1 payment — averaging $10,000 each. An ownership or investment interest held by the physician or an immediate family member.

Surgical Planning Associates, Inc.$10K

What the payments were for

Royalty or licence$7,924,62399%
Consulting fees$7,4000%
Speaking & faculty fees$39,6560%
Travel & lodging$3,7130%
Food & beverage$6,0400%
Education$1600%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Microport Orthopedics Inc	49	$5,540,585
Surgical Planning Associates, Inc.	4	$2,431,395
Zimmer Biomet	55	$8,279
Stryker	5	$593
Smith+Nephew	2	$406
Wishbone Medical Inc.	1	$150
Medical Device Business Services, Inc.	1	$120
Johnson & Johnson	1	$28
DJO, LLC	1	$22
Dexcom, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,981,591 in reported general payments places this provider in the 95th percentile of 542 orthopaedic surgery providers in Massachusetts.

See all orthopaedic surgery providers in Massachusetts →

Medicare billing

Part B allowed, 2024

$218,536

Medicare patients

314

Services billed

452

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	86	$49,824
Celecoxib	153	$3,766
ErythromycinErythromycin Base	20	$1,986
Oxycodone Hcl	152	$792
Amoxicillin	187	$448
Ondansetron Hcl	96	$161
Mupirocin	14	$75
Clindamycin Hcl	13	$58
Tramadol Hcl	18	$39
Naproxen	12	$29

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Roxbury Crossing

Paul TornettaBoston$16.3M
Thomas ThornhillBoston$12M
Andrew FreibergBoston$5.9M
Jon WarnerBoston$5.4M
Wolfgang FitzBoston$3.7M
Brian KwonWaltham$1.9M
Simon ChaoNorth Easton$1.6M
Scott SigmanNorth Chelmsford$1.4M
Michael LangworthyNorth Dartmouth$715K
Mark E SteinerBrookline$700K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →